---
title: "IceCure Medical Ltd (ICCM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ICCM.US.md"
symbol: "ICCM.US"
name: "IceCure Medical Ltd"
industry: "Health Care Equipment"
datetime: "2026-05-20T08:34:42.902Z"
locales:
  - [en](https://longbridge.com/en/quote/ICCM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ICCM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ICCM.US.md)
---

# IceCure Medical Ltd (ICCM.US)

## Company Overview

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.icecure-medical.com](https://www.icecure-medical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: C (0.54)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 106 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.92% |  |
| Net Profit YoY | -2.92% |  |
| P/B Ratio | 2.18 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 18509050.26 |  |
| Revenue | 3565000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -217.23% | E |
| Profit Margin | -441.60% | E |
| Gross Margin | 32.38% | C |
| Revenue YoY | 8.92% | B |
| Net Profit YoY | -2.92% | C |
| Total Assets YoY | 19.80% | A |
| Net Assets YoY | 41.57% | A |
| Cash Flow Margin | 94.05% | C |
| OCF YoY | 8.92% | B |
| Turnover | 0.29 | D |
| Gearing Ratio | 36.15% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - IceCure Medical Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.92%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-2.92%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.18",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "18509050.26",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3565000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-217.23%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-441.60%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "32.38%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "8.92%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-2.92%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "19.80%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "41.57%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "94.05%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "8.92%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.29",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "36.15%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.18 | 87/183 | - | - | - |
| PB | 2.18 | 58/183 | 18.94 | 8.36 | 4.38 |
| PS (TTM) | 5.19 | 94/183 | 21.41 | 16.88 | 13.44 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 67% |
| Overweight | 1 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.23 |
| Highest Target | 2.45 |
| Lowest Target | 1.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ICCM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ICCM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ICCM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ICCM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**